High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer

[1] Rondón-Lagos M(2016)Tamoxifen resistance: emerging molecular targets IJMS 17 1357-1194

[2] Villegas V(2021)Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020 Cancer Commun (Lond) 41 1183-10874

[3] Rangel N(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869-513

[4] Sánchez M(2020)Overcoming endocrine resistance in breast cancer Cancer Cell 37 496-438.e6

[5] Zaphiropoulos P(2020)Methylome variation predicts exemestane resistance in advanced ER Technol Cancer Res Treat 19 153303381989633-3629

[6] Lei S(2018) breast cancer Cancer Cell 34 427-4657

[7] Zheng R(2022)The genomic landscape of endocrine-resistant advanced breast cancers Clin Cancer Res 28 3618-799

[8] Zhang S(2010)Integrated DNA and RNA sequencing reveals drivers of endocrine resistance in estrogen receptor-positive breast cancer Oncogene 29 4648-2125

[9] Wang S(2014)Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance Ann Surg 259 793-404

[10] Chen R(2014)Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy Clin Cancer Res 20 2115-2849

[1] Rondón-Lagos M(2016)Tamoxifen resistance: emerging molecular targets IJMS 17 1357-1194

[2] Villegas V(2021)Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020 Cancer Commun (Lond) 41 1183-10874

[3] Rangel N(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869-513

[4] Sánchez M(2020)Overcoming endocrine resistance in breast cancer Cancer Cell 37 496-438.e6

[5] Zaphiropoulos P(2020)Methylome variation predicts exemestane resistance in advanced ER Technol Cancer Res Treat 19 153303381989633-3629

[6] Lei S(2018) breast cancer Cancer Cell 34 427-4657

[7] Zheng R(2022)The genomic landscape of endocrine-resistant advanced breast cancers Clin Cancer Res 28 3618-799

[8] Zhang S(2010)Integrated DNA and RNA sequencing reveals drivers of endocrine resistance in estrogen receptor-positive breast cancer Oncogene 29 4648-2125

[9] Wang S(2014)Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance Ann Surg 259 793-404

[10] Chen R(2014)Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy Clin Cancer Res 20 2115-2849